dockets: FDA-2026-P-12383

Regulatory dockets from Regulations.gov — containers for related documents and comments in a rulemaking proceeding.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id title docket_type last_modified object_id rin dkabstract category subtype keywords program short_title effective_date organization attrs_raw attr_source
FDA-2026-P-12383 FDA Requests that the FDA use one or more lawful mechanisms to require or secure a postmarketing evidence-generation program that includes the following components: Postmarketing studies and a National Patient Registry. Nonrulemaking 2026-10-14T00:03:37Z 0b000064b96646a2                     list_pull

Links from other tables